Claudia Ordonez, Chief Medical Officer at Keros Therapeutics, Inc. (KROS), sold 1,000 shares at $50.48 ($51K) on 2021-06-11, disclosed to the SEC on 2021-06-15.
Scheduled sale ($51k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.48 | 653 | $33K | 64.6% |
| 2 | $51.95 | 347 | $18K | 35.4% |
| Total | $50.99 avg | 1,000 | $51K | 100% |
| Filing → |
| KROS | SELL | 2021-03-15 | $65K | — | Filing → |
| KROS | SELL | 2021-02-16 | $65K | — | Filing → |